Statement: English name changed from "HuiGene Therapeutics Co., Ltd." to "HuidaGene Therapeutics Co., Ltd.e "

Effective January 28, 2023, the English name of the Company will be officially changed from "HuiGene Therapeutics Co. Ltd." as the unified English name of the company worldwide, and the Chinese name "HuidaGene" remains the same. The company's brand identity was updated to HuidaGene Therapeutics at the same time.

"The launch of HG004 international multi-center clinical trial marks the new journey of HuidaGene towards internationalization, the updated name and logo will also serve as the company's unified English name and image logo for the world. HuidaGene will rely on its self-developed CRISPR gene editing technology, iterative upgrade of its own technology platform, accelerate to meet the urgent clinical needs of patients in China and around the world, and truly realize the mission vision of making gene therapy benefit millions of patients." Dr. Xuan Yao, co-founder and CEO of HuidaGene, said.